Evaluation of Retinal Changes in Systemic Darbepoetin Alpha Treatment in Patients With Diabetes Mellitus
NCT00704652 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2015-04-07
Summary
The purpose of this study is to determine whether systemic administration of darbepoetin alpha results in the progression or regression of diabetic macular edema.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
-
Medical University of Vienna
lead OTHER
Principal Investigators
-
Ursula Schmidt-Erfurth, Prof. · Departmen of Ophthalmology, Medical Unversity of Vienna
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2009-09-30
- Completion
- 2009-09-30
Countries
- Austria
Study Locations
More Related Trials
-
A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)
NCT00457470 ·Status: WITHDRAWN ·Phase: PHASE2
-
Vascular Reparative Mechanism in Diabetes
NCT02119689 ·Status: ACTIVE_NOT_RECRUITING
-
Adaptive Optics for Ophthalmic Technologies
NCT02826655 ·Status: TERMINATED ·Phase: NA
-
Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
NCT00320814 ·Status: COMPLETED ·Phase: PHASE1
-
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes
NCT07270133 ·Status: NOT_YET_RECRUITING
-
Diabetic Retinopathy and Visual Function Study
NCT00001346 ·Status: COMPLETED
-
Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.
NCT00170742 ·Status: TERMINATED ·Phase: PHASE3
-
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
NCT01625598 ·Status: COMPLETED
-
Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy
NCT06582472 ·Status: RECRUITING
-
Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections
NCT04563299 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO
NCT06495203 ·Status: COMPLETED
-
Serum and Intraocular Levels of Erythropoietin and VEGF in Type 2 Diabetes Patients With Proliferative Retinopathy
NCT01871207 ·Status: COMPLETED
-
The Effect of Dopamine on Diabetic Retinopathy
NCT02706977 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema
NCT00799227 ·Status: COMPLETED ·Phase: PHASE2
-
Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME.
NCT06846073 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales
NCT06914778 ·Status: RECRUITING
-
Phase II Combination Steroid and Anti-VEGF for Persistent DME
NCT01945866 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density
NCT03361709 ·Status: WITHDRAWN ·Phase: PHASE4
-
Biomarkers of Diabetic Retinopathy Progression
NCT01607190 ·Status: COMPLETED
-
A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema
NCT02876393 ·Status: COMPLETED
-
Skin and Retina Microvascular Endothelial Function in Healthy, Insulin Resistant and Type 2 Diabetic Subjects
NCT01241370 ·Status: COMPLETED
-
The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes
NCT00337298 ·Status: COMPLETED ·Phase: NA
-
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
NCT00536692 ·Status: COMPLETED ·Phase: PHASE2
-
Vision Response to Dopamine Replacement
NCT01663935 ·Status: TERMINATED ·Phase: PHASE2
-
Blood Factors and Diabetic Retinopathy
NCT00005761 ·Status: COMPLETED